FDA Alert: Erbe USA Recalls Flexible Cryoprobes Over Rupture Risk, Threatening Hearing and Safety

A critical medical device recall is underway after the FDA confirmed that certain Erbe flexible cryoprobes can rupture during activation. This failure poses a direct and serious threat to patient safety, with the potential to cause sudden hearing loss, tinnitus, physical injury, or burns during surgical procedures. The manufacturer, Erbe USA, has initiated the removal of the affected devices from the market.

The recall targets specific models of Erbe's flexible cryoprobes, which are used in various surgical applications, often involving delicate tissues. The core defect—a rupture upon activation—transforms a standard medical tool into an immediate source of harm within the operating room. The FDA's MedWatch alert underscores that the risk is not theoretical but linked to a functional failure of the device itself, elevating the urgency for healthcare facilities to identify and sequester all affected units.

This action places significant pressure on hospitals and surgical centers to audit their inventory and halt the use of these probes immediately to prevent patient harm. The incident triggers heightened regulatory scrutiny for Erbe USA's quality control and manufacturing processes. For the medical device sector, it serves as a stark warning about the latent risks in specialized surgical equipment and the cascading liability when a core component fails under normal use conditions.